Cargando…

Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis

Endocrine pancreatic insufficiency secondary to acute pancreatitis (AP) drew increasing attention in the recent years. The aim of the present study was to assess the impact of pancreatic necrosis and organ failure on the risk of developing new-onset diabetes after AP. The follow-up study was conduct...

Descripción completa

Detalles Bibliográficos
Autores principales: Tu, Jianfeng, Yang, Yue, Zhang, Jingzhu, Yang, Qi, Lu, Guotao, Li, Baiqiang, Tong, Zhihui, Ke, Lu, Li, Weiqin, Li, Jieshou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392884/
https://www.ncbi.nlm.nih.gov/pubmed/29851776
http://dx.doi.org/10.1097/MD.0000000000010713
_version_ 1783398575057666048
author Tu, Jianfeng
Yang, Yue
Zhang, Jingzhu
Yang, Qi
Lu, Guotao
Li, Baiqiang
Tong, Zhihui
Ke, Lu
Li, Weiqin
Li, Jieshou
author_facet Tu, Jianfeng
Yang, Yue
Zhang, Jingzhu
Yang, Qi
Lu, Guotao
Li, Baiqiang
Tong, Zhihui
Ke, Lu
Li, Weiqin
Li, Jieshou
author_sort Tu, Jianfeng
collection PubMed
description Endocrine pancreatic insufficiency secondary to acute pancreatitis (AP) drew increasing attention in the recent years. The aim of the present study was to assess the impact of pancreatic necrosis and organ failure on the risk of developing new-onset diabetes after AP. The follow-up study was conducted for patients recovered from AP in the treatment center of Jinling Hospital. Endocrine function was evaluated by simplified oral glucose tolerance test (OGTT). Pancreatic necrosis was examined by abdominal contrast-enhanced CT (CECT) scan during hospitalization. The data including APACHE II score, Balthazar's score, organ failure (AKI and ARDS) was also collected from the medical record database. All patients were divided into group diabetes mellitus (DM) and group non-DM according to the endocrine function and group pancreatic necrosis (PN) and persistent organ failure (OF), group PN and non-OF, group non-PN and OF, and group non-PN and non-OF according to the occurrence of pancreatic necrosis and persistent organ failure. Around 256 patients were included for the final analysis. 154 patients (60.2%) were diagnosed with DM (include impaired glucose tolerance, IGT), while 102 patients (39.8%) were deemed as normal endocrine function. APACHE II score and Balthazar score of the patients in the group DM were significant higher than those in the non-DM group (F = 6.09, P = .01; F = 10.74, P = .001). The incidence of pancreatic necrosis in group DM and group non-DM was, respectively, 64.7% and 53.0% (χ(2) = 3.506, P = .06). The patients underwent necrosis debridement by percutaneous catheter drainage (PCD) and/or the operative necrosectomy (ON) were more likely to developed new onset DM than the patients without PCD or ON (χ(2) = 2.385, P = .02). The morbidity of new-onset DM after AP gradually increased from group non-PN and non-OF, group non-PN and OF, group PN and non-OF to group PN and OF in order (χ(2) = 4.587, P = .03). The value of HOMA-IR of patients at follow-up time was significant higher in group DM than group non-DM (F = 13.414, P = .000). Patients with both PN and persistent OF may were at increased risk of developing new-onset diabetes after AP. Insulin resistance could be the pivotal mechanism of the development of diabetes.
format Online
Article
Text
id pubmed-6392884
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-63928842019-03-15 Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis Tu, Jianfeng Yang, Yue Zhang, Jingzhu Yang, Qi Lu, Guotao Li, Baiqiang Tong, Zhihui Ke, Lu Li, Weiqin Li, Jieshou Medicine (Baltimore) Research Article Endocrine pancreatic insufficiency secondary to acute pancreatitis (AP) drew increasing attention in the recent years. The aim of the present study was to assess the impact of pancreatic necrosis and organ failure on the risk of developing new-onset diabetes after AP. The follow-up study was conducted for patients recovered from AP in the treatment center of Jinling Hospital. Endocrine function was evaluated by simplified oral glucose tolerance test (OGTT). Pancreatic necrosis was examined by abdominal contrast-enhanced CT (CECT) scan during hospitalization. The data including APACHE II score, Balthazar's score, organ failure (AKI and ARDS) was also collected from the medical record database. All patients were divided into group diabetes mellitus (DM) and group non-DM according to the endocrine function and group pancreatic necrosis (PN) and persistent organ failure (OF), group PN and non-OF, group non-PN and OF, and group non-PN and non-OF according to the occurrence of pancreatic necrosis and persistent organ failure. Around 256 patients were included for the final analysis. 154 patients (60.2%) were diagnosed with DM (include impaired glucose tolerance, IGT), while 102 patients (39.8%) were deemed as normal endocrine function. APACHE II score and Balthazar score of the patients in the group DM were significant higher than those in the non-DM group (F = 6.09, P = .01; F = 10.74, P = .001). The incidence of pancreatic necrosis in group DM and group non-DM was, respectively, 64.7% and 53.0% (χ(2) = 3.506, P = .06). The patients underwent necrosis debridement by percutaneous catheter drainage (PCD) and/or the operative necrosectomy (ON) were more likely to developed new onset DM than the patients without PCD or ON (χ(2) = 2.385, P = .02). The morbidity of new-onset DM after AP gradually increased from group non-PN and non-OF, group non-PN and OF, group PN and non-OF to group PN and OF in order (χ(2) = 4.587, P = .03). The value of HOMA-IR of patients at follow-up time was significant higher in group DM than group non-DM (F = 13.414, P = .000). Patients with both PN and persistent OF may were at increased risk of developing new-onset diabetes after AP. Insulin resistance could be the pivotal mechanism of the development of diabetes. Wolters Kluwer Health 2018-06-01 /pmc/articles/PMC6392884/ /pubmed/29851776 http://dx.doi.org/10.1097/MD.0000000000010713 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-nc-sa/4.0
spellingShingle Research Article
Tu, Jianfeng
Yang, Yue
Zhang, Jingzhu
Yang, Qi
Lu, Guotao
Li, Baiqiang
Tong, Zhihui
Ke, Lu
Li, Weiqin
Li, Jieshou
Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
title Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
title_full Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
title_fullStr Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
title_full_unstemmed Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
title_short Effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
title_sort effect of the disease severity on the risk of developing new-onset diabetes after acute pancreatitis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6392884/
https://www.ncbi.nlm.nih.gov/pubmed/29851776
http://dx.doi.org/10.1097/MD.0000000000010713
work_keys_str_mv AT tujianfeng effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT yangyue effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT zhangjingzhu effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT yangqi effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT luguotao effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT libaiqiang effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT tongzhihui effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT kelu effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT liweiqin effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis
AT lijieshou effectofthediseaseseverityontheriskofdevelopingnewonsetdiabetesafteracutepancreatitis